We describe the case of septic arthritis in a 58-year-old woman with a history of rheumatoid arthritis and ulcerative colitis on immunosuppressive therapy with rituximab. Treatment with anti-CD20 antibodies (eg, rituximab) leads to an immediate depletion of B cells and hence risk of reductions in immunoglobulins and increased risk of infections. This effect may last long after drug cessation. is commensal to the genitourinary tract in sexually active adults. Extragenital infections including septic arthritis are rare, but hypogammaglobulinaemia is a predisposing factor. As requires extended culture, special media or PCR analysis, it is not tested routinely, which in many cases delays diagnosis and correct treatment. In our case, a diagnosis of septic arthritis was made after 9 weeks by PCR analysis and culture of joint fluid. The patient responded well to an 8-week treatment course of moxifloxacin and doxycycline.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817823PMC
http://dx.doi.org/10.1136/bcr-2020-237798DOI Listing

Publication Analysis

Top Keywords

septic arthritis
16
rheumatoid arthritis
8
pcr analysis
8
arthritis
5
septic
4
arthritis patient
4
patient hypogammaglobinaemia
4
hypogammaglobinaemia rheumatoid
4
arthritis describe
4
describe case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!